Aims/hypothesis In adipocytes, triacylglycerol synthesis depends on the formation of glycerol 3-phosphate, which originates either from glucose, through glycolysis, or from lactate, through glyceroneogenesis. However, glucose is traditionally viewed as the main precursor of the glycerol backbone and thus, enhanced glucose uptake would be expected to result in increased triacylglycerol synthesis and contribute to obesity. Methods To further explore this issue, we generated a mouse model with chronically increased glucose uptake in adipose tissue by expressing Gck, which encodes the glucokinase enzyme.
Introduction
Obesity is a growing problem in Western society, and is associated with type 2 diabetes, insulin resistance, hypertension and dyslipidaemia. Obesity results from an imbalance between energy intake and expenditure, leading to increased energy storage in the form of triacylglycerol in white adipose tissue (WAT). Adipocytes synthesise triacylglycerol by esterification of non-esterified fatty acids with glycerol 3-phosphate; net lipid deposition occurs when the rate of esterification is higher than the rate of lipolysis. The synthesis of triacylglycerol depends on the formation of glycerol 3-phosphate, which may originate either from glucose through glycolysis, or from lactate and pyruvate through glyceroneogenesis [1] [2] [3] . Overproduction of the key enzyme of glyceroneogenesis, phosphoenolpyruvate carboxykinase (PEPCK), in adipose tissue leads to increased glycerol 3-phosphate, NEFA re-esterification, adipocyte hypertrophy and obesity [4] . This is associated with higher susceptibility to diet-induced insulin resistance and obesity [5] . In contrast, the ablation of PEPCK in adipose tissue leads to reduced triacylglycerol deposition and lipodystrophy [6] . In addition, although there are few studies of the relative contribution of pyruvate, via glyceroneogenesis, vs glucose, via glycolysis, to glyceride-glycerol synthesis, it has been demonstrated that glyceroneogenesis is quantitatively the predominant source of glycerol in triacylglycerol [7, 8] . However, glucose is still traditionally viewed as the main precursor of the glycerol backbone.
Glucose transport is considered a key regulatory step in insulin-stimulated glucose utilisation in adipocytes. In obesity and type 2 diabetes, insulin resistance leads to decreased adipose tissue glucose uptake, which parallels the downregulation of glucose transporter 4 production in adipose tissue [9] [10] [11] [12] . In adipose-specific Glut4 (also known as Slc2a4) knockout mice, insulin-stimulated glucose transport, glucose disposal and insulin sensitivity in adipose tissue are impaired [13] [14] [15] . Thus, a primary defect in adipocyte glucose uptake induces insulin resistance in other insulin-target tissues, probably through a factor secreted by adipose tissue, such as retinol binding protein-4 (RBP-4) [13, 14, 16] . Nevertheless, despite a marked decrease in glucose transport, these mice do not show differences in adipose mass and adipocyte size [13, 14] . This suggests that lipid synthesis in adipose tissue is not dependent on insulin-stimulated glucose uptake. However, increased insulin-stimulated glucose uptake in adipose tissue from transgenic mice overexpressing Glut4 in adipocytes leads to higher fat mass, though the main part of the glucose is metabolised to lactate (70%) [17] [18] [19] . In addition to glucose transport, glucose utilisation also depends on glucose phosphorylation. In adipocytes, glucose is mainly phosphorylated by hexokinase II (HKII) which, together with GLUT4, controls insulin-stimulated glucose utilisation. Hexokinase II is considered regulatory when glucose transport is maximally stimulated, through feedback inhibition of the enzyme by glucose 6-phosphate [20] [21] [22] .
Therefore, we hypothesised that enhanced glucose uptake and metabolism in adipose tissue would result in increased triacylglycerol synthesis and contribute to obesity. Thus, transgenic mice were engineered to increase adipose tissue glucose phosphorylation by producing the liver enzyme glucokinase (GK). In contrast to HKII, GK has a high K m for glucose (5-8 mmol/l) and its activity is not inhibited by glucose 6-phosphate [23] . We found that in transgenic mice expressing Gck, increased glucose uptake in adipose tissue did not lead to higher glycerol 3-phosphate levels and fat mass, but to an increase in lactate production and to improved whole-body insulin sensitivity and glucose tolerance.
Methods
Generation of transgenic mice A 3.1 kb XmaI-NotI fragment containing the rat hepatic Gck cDNA and the polyadenylation signal of the SV40 virus was introduced downstream of the Ap2 (also known as Fabp4) promoter at the XmaI-NotI site in the pAp2 plasmid [24, 25] . The entire Ap2-Gck chimeric gene (8.5 kb) was microinjected into fertilised eggs as described by our group elsewhere [4] . Mice were tested for the presence of the transgene by Southern blot with a probe radiolabelled with deoxycytidine 5′-[ 32 P]triphosphate (Amersham Pharmacia Biotech, Piscataway, NJ, USA) by random oligopriming (Amersham). C57Bl6/SJL mice were fed ad libitum with a standard diet (Panlab, Barcelona, Spain) and maintained under a light-dark cycle of 12 h (lights on at 09:00). When stated, mice were starved for 16-18 h. Isofluorane-anaesthetised mice were killed by decapitation and samples were taken between 09:00 and 10:00. In the experiments described below, male mice, aged 4 and 6 months, were used. We used littermates as controls. Control and transgenic male mice aged 2 months were kept in individual cages and fed a high-fat diet (TD 88137; Tekland, Madison, WT, USA) or a standard diet for up to 11 weeks. All experimental procedures involving mice were approved by the Ethics and Experimental Animal Committee of the Universitat Autònoma de Barcelona, Spain.
Cell culture and transient transfection of 3T3-L1 adipocytes and adipocytes isolation 3T3-L1 pre-adipocytes were cultured and differentiated as previously described with some modification [26] and as detailed in the Electronic supplementary material (ESM). Transient transfection of 3T3-L1 cells was performed using Lipofectamine 2000 (Invitrogen Life Sciences, Carlsbad, CA, USA) according to the manufacturer's instructions with some modifications as detailed in the ESM. Briefly, differentiated cells were incubated for 24 h with a mixture of DNA/lipofectamine (respectively 7 μg and 7 μl per well of six well plates) in Opti-MEM medium (Invitrogen). Isolation of adipocytes from epididymal fat pad was performed using a modification of the Rodbell's method [27] as detailed in the ESM.
RNA and protein analysis Total RNA was obtained as previously described by our group [4] . Northern blot, RT-PCR using Omniscript Reverse transcriptase kit (Qiagen, Hilden, Germany) and real-time quantitative PCR using QuantiTect SYBR Green (Qiagen) and SmartCyclerII II (Cepheid, Sunnyvale, CA, USA) was performed following the manufacturers' instructions and as detailed in the ESM. The sequences of oligonucleotide primers are given in the ESM (ESM Table 1 ). Western blot analysis was performed using standard procedures with total homogenates of WAT, skeletal muscle and liver [4] . The antibodies used are described in the ESM.
Metabolic studies using radiolabelled tracers The in vivo glucose utilisation index in epididymal WAT was determined by the intravenous flash injection of deoxy-D-[ 3 H]glucose (Amersham) as previously described by Franckhauser et al. [4] . Uptake of deoxy-D-[ 3 H]glucose was measured in isolated soleus muscles, in 3T3-L1 adipocytes and in isolatedadipocyte suspension incubated with or without insulin as previously described [4, 28, 29] and in the ESM. To determine glucose and pyruvate incorporation into lipids, epididymal fat pads and 3T3-L1 adipocytes were incubated for 2 h with either D-[U- 14 C]glucose or D- [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]pyruvate (PerkinElmer, Waltham, MA, USA) supplemented with glucose as stated in the figure legends. Total lipids, fatty acids and glycerideglycerol were then isolated as previously described [4] . For in vivo pyruvate incorporation, mice were given an intraperitoneal injection of [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]pyruvate and glyceride-glycerol was extracted. Incorporation of 14 C radioactivity was measured and corrected by specific blood pyruvate 14 C clearance.
Body fat content and histological analysis The fat content of mouse carcasses was measured as previously described by Salmon and Flatt [30] . Epididymal fat pads were fixed for 12-24 h in formalin, embedded in paraffin and then sectioned. Sections were stained with haematoxylin/eosin. Quantification of adipocyte size in white adipose tissue and laser-scanning confocal microscopy studies in isolated adipocytes were performed as described in the ESM.
Lactate synthesis from glucose in transgenic mice To investigate in vitro lactate production, epididymal fat pads were incubated in Krebs-Ringer bicarbonate HEPES buffer with 20 mmol/l glucose, and lactate concentrations were measured in the incubation medium at the times indicated. To measure in vivo lactate release, starved mice were given an intraperitoneal injection of glucose and blood samples were obtained from the tail vein before and after the injection. Glucose and lactate concentration were measured in blood samples and incubation media as described in the ESM. For the 13 C-nuclear magnetic resonance (NMR) experiment, mice received an intraperitoneal injection of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose and NMR was performed in perchloric acid extracts of WAT as detailed in the ESM.
Intraperitoneal glucose and insulin tolerance tests Glucose and insulin tolerance tests were performed as previously described [4] and in the ESM. Conscious mice were given an intraperitoneal injection of either glucose or insulin and blood glucose levels were measured from samples obtained by tail vein bleeding before the injection and afterwards at the time points indicated.
Metabolite and hormones assays For metabolite assays in epididymal WAT, gastrocnemius and liver, tissues biopsies were obtained from anaesthetised mice and frozen. Hormone and metabolite concentrations were determined as indicated in the ESM.
Statistical analysis All values are expressed as the means ± SEMs. The significance of differences between data was analysed using the Student-Newman-Keuls test. Differences were considered significant at p<0.05.
Results
Adipose-specific expression of glucokinase led to increased glucose uptake Two independent transgenic lines (Tg1 and ). The results are the means ± SEMs from at least four mice for each group. *p< 0.05. e Expression of glucose transporter genes Glut1 (also known as Slc2a1) and Glut4 in epididymal WAT. The quantification of the level of expression was performed by real-time quantitative PCR using SYBR Green as indicated in the text and the ESM. Data were normalised with 36B4 (also known as Rplp0) values and analysed as described in the text and the ESM. Results are means ± SEM of data from three mice for each group. Control mice, white bars; transgenic mice, black bars. f-k Representative laser-scanning confocal images in isolated transgenic adipocytes. Co-localisation (h, k) of GK (f) and HKII (i) with mitochondria (g, j). GK and HKII were marked with green fluorescent Alexa 488 and mitochondria with orange rosamine MitoTracker. Nuclei of adipocytes were marked with blue Hoechst stain solution. Note that hexokinases and mitochondria surround an empty space corresponding to the unilocular lipid droplet. Scale bar, 11 μm Tg2) expressing hepatic Gck under control of the adiposespecific aP2 promoter were obtained (Fig. 1a) . Transgenic mice showed high levels of Gck mRNA in white adipose tissue and brown adipose tissue (BAT; Fig. 1b) . Furthermore, GK protein was detected in the WAT of Tg2 mice, whereas no GK was noted in the controls (Fig. 1c ). In addition, the level of GK protein in the WAT of Tg2 mice was 20% that of the endogenous hepatic GK level. While skeletal muscle from both control and transgenic mice did not produce GK (results not shown), liver from both groups showed a 2.3 kb mRNA transcript (Fig. 1b) resulting from the expression of the endogenous hepatic Gck gene. Moreover, similar levels of GK protein were detected in the livers of both control and transgenic mice, indicating the adipose specificity of the transgene (Fig. 1c) . The transgenic line with highest Gck expression, Tg2, was used in this study.
In WAT, a significant increase (about 2.5-fold) in the glucose utilisation index, evaluated by measuring 2-deoxy- . Results are means ± SEMs from 3,748 adipocytes from control mice and 5,015 adipocytes from transgenic mice [1- 3 H]glucose uptake in vivo, was observed in transgenic mice (Fig. 1d) . In addition, production of glucose transporters 1 and 4 in the adipose tissue of transgenic mice was similar to that in controls (Fig. 1e) . This suggests that the specific increase in adipose tissue glucose uptake in transgenic mice was due to the presence of GK in WAT.
In order to examine the subcellular localisation of GK, the percentage of co-localisation of GK with mitochondria was determined and compared with that of endogenous hexokinase, HKII. To this end, both enzymes were immunodetected in isolated adipocytes from transgenic mice and visualised by laser-scanning confocal microscopy ( Fig. 1f-k) . In transgenic mice, similar percentages of HKII and GK co-localised with mitochondria (HKII, 41.05±9.58% vs GK, 39.37±15.88%; n=12), indicating a similar subcellular distribution.
Glucokinase production in adipose tissue does not increase adiposity The effect of glucokinase production on lipid storage in adipose tissue was further examined. Body weight, epididymal fat pad weight and body fat content were similar in transgenic and control mice (Fig. 2a-c) . Moreover, the frequency of distribution and mean adipocyte size from control and transgenic mice were similar ( Fig. 2d-g ). These findings indicate that the transgenic mice did not develop adipose tissue hypertrophy and/or hyperplasia.
Similarly, in agreement with the lack of extra fat accumulation in transgenic mice, serum levels of adiponectin and leptin, as well as circulating NEFA, glycerol, triacylglycerol and β-hydroxybutyrate in the transgenic mice were similar to those in the controls (Table 1) .
Increased glucose uptake in adipose tissue does not lead to increased glycerol 3-phosphate synthesis In ex vivo epididymal WAT from transgenic mice, [ 14 C]glucose conversion into lipids, fatty acids or glyceride-glycerol synthesis Real-time quantitative PCR data were normalised with 36B4 values and results are means ± SEMs from at least four mice for each group. Densitometry of western blot results are means ± SEMs from eight 4-month-old mice for each group. FA, fatty acid; Gly-gly, glycerideglycerol. *p<0.05 vs control unless otherwise specified (glycerogenesis) in the presence of 5 mmol/l non-labelled glucose was not altered compared with control mice (Fig. 3a) . Similar results were observed in the presence of 20 mmol/l glucose (data not shown).
The alternative pathway involved in glyceride-glycerol synthesis, glyceroneogenesis, was also examined. In the absence of glucose, WAT explants from transgenic mice had higher rates of pyruvate incorporation into lipid, fatty acids or glyceride-glycerol (Fig. 3b) . In the presence of 5 mmol/l glucose, [ 14 C]pyruvate incorporation into glyceride-glycerol was increased in WAT explants producing GK compared with control WAT (Fig. 3c) . At high concentrations of glucose (20 mmol/l), the pyruvate conversion rate was further increased in WAT from control mice while it decreased in WAT from transgenic mice (Fig. 3c) . Moreover, the increase in glyceroneogenesis observed in transgenic mice was parallel to higher expression of Pepck (Fig. 3d) . However, expression of the main Pepck adipospecific transcriptional regulator, peroxisome proliferatoractivated receptor γ2 (PPARγ2) remained unchanged (Fig. 3d) . In contrast, a significant increase in the expression of both Lipin1 (also known as Lpin1) mRNA and protein, a factor specifically recruited to the PPARγ 2 -response element of the Pepck promoter, was observed in WAT from transgenic mice (Fig. 3d, e) [31] . However, despite an increase in both Pepck expression and in the glyceroneogenic rate observed in vitro, no change was observed in fat accumulation in these mice. Thus, labelled pyruvate incorporation into glyceride-glycerol was measured in vivo in fed control and transgenic mice. Under these conditions, the glyceroneogenic rate was similar in control and transgenic mice (Fig. 3f) .
In order to evaluate the effect of glucose on pyruvate incorporation into lipids and glyceride-glycerol, as well as to study the effect of overproduction of the key endogenous enzyme in glucose phosphorylation, HKII, 3T3-L1 adipocytes were transiently transfected to produce GK, HKII or green fluorescent protein (GFP) as a control of transfection (Fig. 4a, b) . In cells overexpressing either HkII (also known as Hk2) or Gck, 2-deoxyglucose uptake was increased (Fig. 4c) . In the presence of 5 mmol/l glucose, [ 14 C]pyruvate incorporation into glyceride-glycerol and lipids, and Pepck expression were increased in cells overexpressing Gck or HkII compared with control cells (Fig. 4d-f) . At the high concentration of glucose (20 mmol/l), the pyruvate conversion rate increased in HkII-expressing cells while the glyceroneogenic rate was decreased in Gck-expressing adipocytes (Fig. 4d, e) . This suggests that, at high glucose concentration, the inhibition of HKII activity by glucose 6-phosphate leads to an increase in glyceroneogenesis, whereas an increase in glycolytic flux due to GK activation leads to a decrease in glyceroneogenesis.
Increased glucose uptake in adipose tissue leads to higher lactate formation The effect of an increase in adipose glucose uptake on circulating lactate levels was further examined. Plasma lactate levels were increased in fed but not starved transgenic mice (Fig. 5a ), whereas glucose levels were not altered (Fig. 5b) . Lactate concentrations increased in starved transgenic and control mice at 30 min after a glucose injection (Fig. 5a) . However, lactate levels were higher in transgenic mice than in control mice, though blood glucose levels were lower (Fig. 5b) . This is as would be expected if glucose uptake by adipose tissue had increased. The fate of glucose in adipose tissue was then confirmed by 13 C-NMR spectroscopy. The main difference Glucose homeostasis and whole-body insulin sensitivity in Gck-expressing transgenic mice (Tg) and control mice (Con). a, b Glucose tolerance test. Awake overnight-fasted control mice and transgenic mice were given an intraperitoneal injection of glucose at 1 g/kg body weight (a) and 2 g/kg body weight (b). Blood samples were taken at the times indicated from the tail vein of the same animal. c, d Insulin tolerance test. Insulin at 0.75 U per kg body weight (c) or 0.375 U per kg body weight (d) was injected intraperitoneally into awake fed mice. Blood samples were taken from the tail vein of the same animals at the times indicated and glucose levels were determined. Results of tolerance tests are means ± SEMs from at least eight mice for each group. Control mice, white squares; transgenic mice, black diamonds. *p<0.05 vs control between the 13 C spectra of WAT from transgenic and control mice were higher levels of [3- 13 C]lactate in transgenic extracts, indicating an increase (about twofold) in [1- 13 C]glucose conversion to lactate (Fig. 5c ). When adipose tissue explants were incubated in the presence of glucose, higher levels of lactate accumulated in the incubation medium of WAT from transgenic mice than in the medium with WAT from control mice (Fig. 5d) . This occurred in parallel with a decrease in glucose concentration in the medium (data not shown).
Metabolic changes in the liver of Gck-expressing mice The effect of the increased circulating lactate concentration on hepatic metabolism was examined next. No change in hepatic glucose 6-phosphate content was observed in control and transgenic mice kept under either fed or starved conditions (Table 1 ). However, during starvation, transgenic mice had higher levels of hepatic glycogen (about fourfold) than those of controls. In addition, under fed conditions, transgenic livers had a higher triacylglycerol content (by about 40%) than controls (Table 1) . These results suggest that lactate released by adipose tissue may have contributed to glycogen and triacylglycerol synthesis in the liver.
Glucose homeostasis in glucokinase-expressing transgenic mice It has been suggested that high levels of circulating lactate observed during obesity may contribute to insulin resistance [32] [33] [34] [35] [36] [37] . However, no difference in serum insulin concentration was observed in fed or starved transgenic mice compared with controls (Table 1 ). An intraperitoneal glucose tolerance test was also performed. After injecting glucose at 1 or 2 g per kg body weight, glycaemia reached a lower level in transgenic mice compared with controls, indicating higher glucose disposal in the transgenic mice (Fig. 6a, b) . In addition, insulin sensitivity was measured by insulin tolerance tests at two doses of insulin (0.75 and 0.375 U/kg body weight). Fed control and transgenic mice showed similar responses to a high dose of insulin (Fig. 6c) . However, when the lower dose of insulin was injected, a hypoglycaemic response of greater magnitude was observed in transgenic mice (Fig. 6d) . In order to determine whether glucokinase production led to increased insulin sensitivity Fig. 7 Insulin sensitivity of adipose tissue in Gck-expressing transgenic mice (Tg) and control mice (Con). a The insulin dose/ glucose-uptake response in isolated adipocytes from control mice (white squares) and transgenic mice (black diamonds) was analysed. * p<0.05. b Densitometric quantification of phospho-AKT(Ser473) was normalised to total AKT protein levels by western blots of epididymal WAT from starved control mice and transgenic mice with (+) or without (−) insulin stimulation. c Representative western blots of GLUT4 and GLUT1 protein in the plasma membrane of epididymal WAT from starved control mice (Con) and transgenic (Tg) mice with (+) or without (−) insulin stimulation. d, e Densitometric quantification of GLUT4 (d) and GLUT1 (e) protein levels was performed using sodium potassium ATPase protein as the membrane loading control. The results are the means ± SEMs from at least four mice for each group. *p<0.05 vs control −insulin; † p<0.05 vs transgenic −insulin. 2DG, 2-deoxy-D- [1- of adipose tissue, the response in glucose uptake to insulin dose in isolated adipocytes from control and transgenic mice was measured. Adipocytes from transgenic mice had higher rates of glucose uptake in the absence or presence of increasing doses of insulin (Fig. 7a) . However, the half maximal effective concentration, EC 50 , was similar in control and transgenic mice (control EC 50 0.32 nmol/l and transgenic EC 50 0.37 nmol/l). Similarly, in adipose tissue, basal and insulin-stimulated phosphorylation of protein kinase B/AKT on serine 473 remained unchanged (Fig. 7b) . In addition, translocation of either of the GLUT4 or GLUT1 glucose transporters to the plasma membrane in response to insulin was not altered in transgenic mice compared with control mice (Fig. 7c-e) .
In agreement with increased whole-body insulin sensitivity, insulin-stimulated glucose uptake was higher in skeletal muscle from transgenic mice (Fig. 8a) . In addition, a slight increase in basal and insulin-stimulated phosphorylation of AKT was also observed in skeletal muscle from transgenic mice (Fig. 8b) . The decreased expression of Rbp4 in adipose tissue and the subsequent decrease in RBP-4 serum levels in transgenic mice may have contributed to higher insulin sensitivity in these mice (Fig. 8c, d) .
Finally, in order to examine whether expression of Gck in adipose tissue prevents diet-induced insulin resistance, mice were fed a high-fat diet. Body weight gain, fat pad weight and histological analysis of WAT revealed similar fat accumulation between transgenic and control mice (Fig. 9a-d) . In addition, serum levels of triacylglycerol, leptin and adiponectin remained unchanged between both groups (Fig. 9e-g ). In contrast, circulating insulin levels tended to be lower in transgenic than in control mice, although mice remained normoglycaemic (Fig. 9h, i) . Whole-body insulin sensitivity was also measured. In fatfed control mice, the hypoglycaemic effect of insulin was reduced compared with control mice fed a chow diet, while the insulin response of fat-fed transgenic mice was similar to the control response (Fig. 9j) . This indicates that transgenic mice, when fed a high-fat diet, became obese similarly to controls, but remained insulin sensitive.
Discussion
It is generally accepted that lipid storage in adipose tissue depends mainly on insulin-stimulated glucose uptake to generate the glycerol 3-phosphate necessary for fatty acid esterification. In this study we show that expression of Gck selectively in adipose tissue of transgenic mice leads to increased glucose uptake in this tissue, but not to glycerol 3-phosphate formation and fat accumulation. Furthermore, we demonstrated that the increased glucose flux in adipose tissue led to increased lactate release and higher circulating lactate levels within the physiological range. Similarly, in Glut4-overexpressing mice, the majority of glucose was metabolised to lactate (70%) [17] . This is also consistent with results obtained in transgenic mice expressing Gck in skeletal muscle or in the liver, in which serum lactate concentrations were increased [24, 29] . Moreover, in these mice, the increase of lactate production by hepatocytes occurred only at high glucose concentration [24] . Similarly, transgenic mice expressing Gck in adipose tissue displayed increased lactate levels only in fed conditions or after a glucose load. This probably reflects the potent activation of Representative western blot of circulating RBP-4 protein levels from 2 μl serum samples. Densitometric quantification of circulating RBP-4 protein levels was performed by using Ponceau staining. The results from the ex vivo study, Rbp4 expression and western blots of serum samples are means ± SEMs from at least four mice for each group. * p<0.05 vs control unless otherwise specified Gck by glucose [38] . Therefore, our results are consistent with a view of adipose tissue as an active producer of lactate [39] . This is also in line with the results from microdialysis studies on humans showing a net release of lactate from adipose tissue after glucose ingestion [40] [41] [42] . The paradoxical increase of a gluconeogenic precursor in the postprandial state may be related to a possible role of lactate in insulin-dependent inhibition of lipolysis [43] as well as a liver glycogen or triacylglycerol precursor [44, 45] . In agreement with this, our results suggest that lactate released by adipose tissue is taken up by the liver, where it is converted to glycogen and triacylglycerol, without affecting circulating triacylglycerol and glucose levels.
Moreover, our results suggest that a chronic increase in circulating lactate levels does not lead to insulin resistance. It has been suggested that high levels of circulating lactate observed during obesity contribute to insulin resistance by decreasing glucose utilisation by skeletal muscle and enhancing hepatic gluconeogenesis [32] [33] [34] [35] [36] [37] . Plasma lactate is elevated in obese individuals and this increase is higher when obesity is associated with type 2 diabetes [32] . A similar increase in plasma lactate is also observed in nonobese patients with type 2 diabetes [32, 36] . These increases are in the same range (about 50% increase) as those observed in our transgenic mice. Nevertheless, in the mice, whole-body and skeletal muscle insulin sensitivity and ). e-g Circulating levels of serum triacylglycerol (TG) (e), leptin (f) and adiponectin (g) were measured in fat-fed control mice (white bars) and transgenic mice (black bars). h, i
Circulating levels of serum insulin (h) and glucose (i) were measured in fat-fed control mice (white bars) and transgenic mice (black bars). j Results from the insulin tolerance test. Insulin, 0.375 U per kg body weight, was injected intraperitoneally into chow-fed control mice (white squares), fat-fed control mice (black squares) and fat-fed transgenic mice (black diamonds). Blood samples were taken from the tail veins of the same animals at the times indicated and glucose levels were determined. Results are means ± SEMs from at least seven mice for each group.*p<0.05 vs chow-fed controls; † p<0.05 vs high-fat-fed controls glucose disposal were increased despite higher plasma lactate. Thus, our results indicate that high circulating lactate levels are probably not responsible for insulin resistance.
In our mice, improved glucose tolerance was probably due to increased glucose uptake by adipose tissue, and also to an increase in insulin-stimulated glucose uptake by skeletal muscle. This suggests that an increase in glucose uptake by adipose tissue, without any alteration in fat accumulation, probably led to the secretion of a factor able to regulate insulin sensitivity in skeletal muscle. However, in transgenic mice, no change was observed in circulating levels of hormones affecting glucose homeostasis such as adiponectin or leptin. Although other adipokines may be involved in the increased insulin sensitivity, the observed decrease in adipose tissue expression of Rpb4 and serum levels of RPB-4, a crucial factor in the pathogenesis of insulin resistance, may have contributed to higher skeletal muscle insulin sensitivity. In agreement with this, Glut4-overexpressing transgenic mice also had decreased Rbp4 expression [16] . However, although the regulation of RBP-4 production in WAT remains unclear, our results suggest that it is probably regulated not by lipid accumulation, but by glucose flux into adipose tissue.
Furthermore, despite increased glucose uptake in adipose tissue, transgenic mice expressing Gck did not accumulate more fat. Gck transgenic mice showed neither hypertrophy nor hyperplasia of adipose cells. In contrast, Glut4-overexpressing mice had adipocyte hyperplasia [18] . Nevertheless, despite the higher glucose incorporation into glycerol observed in transgenic mice overexpressing Glut4, their adipocytes did not show increased fat accumulation and 70% of glucose was metabolised to lactate [19] . Similarly, transgenic mice expressing Gck did not have increased fat accumulation and had higher lactate release by adipose tissue. Thus, the main difference between both transgenic models is the presence of adipose cell hyperplasia, which occurred only in Glut4 transgenic mice, suggesting that an increase in glucose uptake by Glut4 overexpression or by Gck expression may have different effects on immature adipocyte replication and/or differentiation.
The lack of excess fat accumulation in mice expressing Gck also highlights the potential dissociation between glucose uptake and triacylglycerol storage in adipose tissue. This agrees with the finding that in adipose-specific Glut4 knockout mice, despite a marked decrease in adipose tissue glucose transport, no alteration in fat storage was observed [13] . This is also consistent with results obtained using labelled glucose, which indicate that uptake of glucose carbon in total body fat is in the order of less than 4% of glucose given [46] . This agrees with the finding that lactate and pyruvate may be utilised preferentially to glucose to produce glycerol for triacylglycerol deposition, and with a recent study in rats showing that quantitatively higher amounts of glycerol are gained, in response to sucrose feeding, from pyruvate/lactate via glyceroneogenesis than from glucose via glycolysis [7, 8, 47] . This suggests that glyceroneogenesis and glycolysis occur simultaneously in adipose tissue in the presence of increased glucose uptake by this tissue. Thus, a compartmentalisation of these pathways has been hypothesised, either in the same cell or in different adipose tissue cell types [7] . However, our data indicate that in adipose tissue expressing glucokinase, in which glucose uptake is increased, glyceroneogenesis decreased at high glucose concentration. Furthermore, this study suggests that in adipose tissue producing the enzyme HKII, glyceroneogenesis increased at high glucose due to the inhibition by glucose 6-phosphate. Therefore, glyceroneogenesis and glycolysis may occur in the same cell, but not at the same time, and the feedback inhibition of HKII by glucose 6-phosphate may permit glyceroneogenesis from lactate to occur after the activation of glycolysis.
In summary, our results suggest that an uncontrolled increase in glycolytic flux in adipose tissue leads to lactate production, rather than to higher glycerol 3-phosphate synthesis, fat accumulation and obesity. Furthermore, they suggest that a chronic increase in circulating lactate levels is not sufficient to lead to insulin resistance and point to the indirect pathway (glucose to lactate to glycerol 3-phosphate) as being key for fat deposition in adipose tissue.
